Chosa Oncology

👥 8 employees💰 Last funded Apr 2020
Biotechnology Research🌐 chosa.bio
Website LinkedIn
CHOSA’s key product is a major upgrade of Cisplatin – a cornerstone drug in oncology It incorporates two precision oncology technologies to improve efficacy & reduce side-effects
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Chosa Oncology?
Chosa Oncology has 1 investors on record on gritt.io.
When did Chosa Oncology last raise funding?
The most recent investment in Chosa Oncology recorded on gritt.io was in April 2020.
What industry is Chosa Oncology in?
Chosa Oncology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.